Scientists Who Made Significant Contribution to Discovery of Lantheus Medical Imaging’s Cardiolite® Honored with Prestigious Nuclear Medicine Award at SNM Annual Meeting Read more about Scientists Who Made Significant Contribution to Discovery of Lantheus Medical Imaging’s Cardiolite® Honored with Prestigious Nuclear Medicine Award at SNM Annual Meeting
Lantheus Medical Imaging, Inc. to Receive LEU-Derived MO-99 from Australian Nuclear Science and Technology Organisation (ANSTO) and Becomes First to Supply U.S. Market Read more about Lantheus Medical Imaging, Inc. to Receive LEU-Derived MO-99 from Australian Nuclear Science and Technology Organisation (ANSTO) and Becomes First to Supply U.S. Market
BARI 2D Study Presented at American Diabetes Association Scientific Sessions Underscores Utility of Spect Myocardial Perfusion Imaging in Identifying Cardiovascular Risk and Evaluating Treatment Outcomes for Patients with Type 2 Diabetes Read more about BARI 2D Study Presented at American Diabetes Association Scientific Sessions Underscores Utility of Spect Myocardial Perfusion Imaging in Identifying Cardiovascular Risk and Evaluating Treatment Outcomes for Patients with Type 2 Diabetes
Spect MPI with Cardiolite® Used in BARI 2D Study to Evaluate Type 2 Diabetes and Coronary Artery Disease Treatment Strategies Read more about Spect MPI with Cardiolite® Used in BARI 2D Study to Evaluate Type 2 Diabetes and Coronary Artery Disease Treatment Strategies
Lantheus Medical Imaging, Inc. Completes Enrollment of Cares Registry to Further Evaluate Definity® in Patients with Suboptimal Echocardiograms Read more about Lantheus Medical Imaging, Inc. Completes Enrollment of Cares Registry to Further Evaluate Definity® in Patients with Suboptimal Echocardiograms
Lantheus Medical imaging, Inc. Takes Proactive Steps to Mitigate Impact of Global Molybdenum-99 Supply Crisis on Operations Read more about Lantheus Medical imaging, Inc. Takes Proactive Steps to Mitigate Impact of Global Molybdenum-99 Supply Crisis on Operations
Lantheus Medical Imaging, Inc. Acquires U.S., Canadian and Australian Rights TO MS-325 (formerly marketed as VASOVIST®, gadofosveset trisodium, by Bayer Schering Pharma) from EPIX Pharmaceuticals Read more about Lantheus Medical Imaging, Inc. Acquires U.S., Canadian and Australian Rights TO MS-325 (formerly marketed as VASOVIST®, gadofosveset trisodium, by Bayer Schering Pharma) from EPIX Pharmaceuticals
Lantheus Medical Imaging Presents Phase I Study Results of Novel Pet Myocardial Perfusion Imaging Tracer aAt ACC Read more about Lantheus Medical Imaging Presents Phase I Study Results of Novel Pet Myocardial Perfusion Imaging Tracer aAt ACC
New Lantheus Study Finds Significant Survival Benefit for Critically Ill Patients Undergoing Contrast-Enhanced Echocardiography Read more about New Lantheus Study Finds Significant Survival Benefit for Critically Ill Patients Undergoing Contrast-Enhanced Echocardiography
Lantheus Medical Imaging to Present New Cardiac Imaging Data at The American College of Cardiology 58th Annual Scientific Sessions in Orlando Read more about Lantheus Medical Imaging to Present New Cardiac Imaging Data at The American College of Cardiology 58th Annual Scientific Sessions in Orlando
